Evidence map›Paper›PMID 24807052›Full record

ArticleClinical and vaccine immunology : CVI2014

Mapping of epitopes recognized by antibodies induced by immunization of mice with PspA and PspC.

Cintia F M Vadesilho, Daniela M Ferreira, Stephen B Gordon, David E Briles, Adriana T Moreno, Maria Leonor S Oliveira, Paulo L Ho, Eliane N Miyaji

Open access · diamondAbstract read
In one paragraph

Article in Clinical and vaccine immunology : CVI, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 28 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. A new candidate epitope-based vaccine against PspA PhtD ofFrontiers in cellular and infection microbiology · 2023
    Article
  6. Review
  7. Mucosal vaccines: wisdom from now and then.International immunology · 2021
    Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Observational
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 3 countries.

Cintia F M VadesilhoCentro de Biotecnologia, Instituto Butantan, São Paulo, Brazil.
Daniela M FerreiraRespiratory Infection Group, Liverpool School of Tropical Medicine, Liverpool, United Kingdom.
Stephen B GordonRespiratory Infection Group, Liverpool School of Tropical Medicine, Liverpool, United Kingdom.
David E BrilesDepartment of Microbiology, University of Alabama at Birmingham, Birmingham, Alabama, USA.
Adriana T MorenoCentro de Biotecnologia, Instituto Butantan, São Paulo, Brazil.
Maria Leonor S OliveiraCentro de Biotecnologia, Instituto Butantan, São Paulo, Brazil.
Paulo L HoCentro de Biotecnologia, Instituto Butantan, São Paulo, Brazil.
Eliane N MiyajiCentro de Biotecnologia, Instituto Butantan, São Paulo, Brazil eliane.miyaji@butantan.gov.br.
Instituto Butantan · BRLiverpool School of Tropical Medicine · GBUniversity of Alabama at Birmingham · US

Funding

Medical Research Council MR/K01188X/1Wellcome Trust 101113
6 · The paper itself

Abstract

Pneumococcal surface protein A (PspA) and pneumococcal surface protein C (PspC) are important candidates for an alternative vaccine against pneumococcal infections. Since these antigens show variability, the use of variants that do not afford broad protection may lead to the selection of vaccine escape bacteria. Epitopes capable of inducing antibodies with broad cross-reactivities should thus be the preferred antigens. In this work, experiments using peptide arrays show that most linear epitopes recognized by antibodies induced in mice against different PspAs were located at the initial 44 amino acids of the mature protein and that antibodies against these linear epitopes did not confer protection against a lethal challenge. Conversely, linear epitopes recognized by antibodies to PspC included the consensus sequences involved in the interaction with human factor H and secretory immunoglobulin A (sIgA). Since linear epitopes of PspA were not protective, larger overlapping fragments containing 100 amino acids of PspA of strain Rx1 were constructed (fragments 1 to 7, numbered from the N terminus) to permit the mapping of antibodies with conformational epitopes not represented in the peptide arrays. Antibodies from mice immunized with fragments 1, 2, 4, and 5 were capable of binding onto the surface of pneumococci and mediating protection against a lethal challenge. The fact that immunization of mice with 100-amino-acid fragments located at the more conserved N-terminal region of PspA (fragments 1 and 2) induced protection against a pneumococcal challenge indicates that the induction of antibodies against conformational epitopes present at this region may be important in strategies for inducing broad protection against pneumococci.

Indexed as

Epitope MappingAmino Acid SequenceAnimalsAntibodiesAntibodies, BacterialBacterial ProteinsComplement Factor HCross ReactionsEpitopesFemaleImmunizationImmunoglobulin AMiceMice, Inbred BALB CMolecular Sequence DataPeptide FragmentsAntibodiesAntibodies, BacterialBacterial ProteinsCFH protein, humanComplement Factor HEpitopesImmunoglobulin APeptide Fragmentspneumococcal surface protein APneumococcal VaccinesSpsA protein, Streptococcus pneumoniae

Identifiers

PMID24807052
PMCPMC4097434
OpenAlexW2120178943

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.